PKM and esophageal cancer: In human esophageal squamous carcinoma Eca109 and Ec9706 cell lines, dihydroartemisinin (DHA) may inhibit the glycolysis of esophageal cancer by downregulating PKM2 expression, hence decreasing tumor cell proliferation (Li et al., 2019c).